Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

NCT01531374 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2777

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Aortic Stenosis

Interventions

DEVICE: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)

Sponsor

Medtronic Cardiovascular